Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01833403 · ClinicalTrials.gov registry record · NA
Metabolomic Analysis of Hepatic Insulin Resistance
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01833403 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 4 participants.
The verdict
NCT01833403, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
This is a pilot study to show that it is possible to identify the specific types of fats in blood, adipose tissue, and liver tissue. The study doctors hope to use the analysis of these fats to learn more about nonalcoholic fatty liver disease (NFLD). Nonalcoholic fatty liver disease is the accumulation of fat in the liver of people who have minimal alcohol exposure. Nonalcoholic Fatty Liver Disease is associated with obesity and insulin resistance, and predicts development of Type 2 Diabetes. The study doctors are interested in looking at the relationship between liver fat and insulin resistance.
Interventions
- OTHER Hyperinsulinemic-euglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01833403
The ClinicalTrials.gov registry entry for NCT01833403 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperinsulinemic-euglycemic clamp is the first listed.
NCT01833403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01833403 about?
NCT01833403 is a clinical study titled "Metabolomic Analysis of Hepatic Insulin Resistance". This is a pilot study to show that it is possible to identify the specific types of fats in blood, adipose tissue, and liver tissue. The study doctors hope to use the analysis of these fats to learn more about nonalcoholic fatty liver disease (NFLD). Nonalcoholic fatty liver disease is the accumulat...
What is the current status of trial NCT01833403?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2013-04. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01833403?
The interventions under investigation include: Hyperinsulinemic-euglycemic clamp (OTHER).
Who is sponsoring clinical trial NCT01833403?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.